Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-12-16 Sale | 2024-12-18 9:03 pm | Akero Therapeutics Inc. | AKRO | Lamy Patrick Senior VP, Commercial Strategy | 1,000 | $29.13 | $29,130 | 86,358 (Direct) | View |
2024-12-10 Sale | 2024-12-12 8:29 pm | Akero Therapeutics Inc. | AKRO | Lamy Patrick Senior VP, Commercial Strategy | 925 | $30.79 | $28,481 | 17,858 (Direct) | View |
2024-06-11 Sale | 2024-06-13 6:04 pm | Akero Therapeutics Inc. | AKRO | Lamy Patrick Senior VP, Commercial Strategy | 569 | $22.64 | $12,883 | 18,562 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-12-16 Option Award | 2024-12-18 9:03 pm | N/A 2034-12-15 | Akero Therapeutics Inc. | AKRO | Lamy Patrick Senior VP, Commercial Strategy | 69,500 | $0 | 86,358 (Direct) | View |
2024-06-28 Option Award | 2024-07-02 6:56 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Lamy Patrick Senior VP, Commercial Strategy | 221 | $19.94 | 18,783 (Direct) | View |
2023-12-08 Option Award | 2023-12-12 4:35 pm | N/A 2033-12-07 | Akero Therapeutics Inc. | AKRO | Lamy Patrick See Remarks | 102,134 | $0 | 102,134 (Direct) | View |
2023-01-10 Option Award | 2023-01-11 7:51 pm | N/A 2033-01-09 | Akero Therapeutics Inc. | AKRO | Lamy Patrick See Remarks | 100,000 | $0 | 100,000 (Direct) | View |